Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
analysts
Biotech
Biotech’s top 5 stock picks for 2026: analyst
William Blair has hand-picked its top five stock recommendations for 2026, selections that include three clinical-stage biotechs in the bunch.
Gabrielle Masson
Dec 23, 2025 10:05am
Bicara CEO: ASCO data resonate more with 'people that matter'
Jun 2, 2025 4:26pm
CROs should brace for continued slow Big Pharma demand: analyst
Jan 28, 2025 3:45pm
CRO and clinical trial markets set for growth by 2030: reports
Dec 4, 2024 3:15pm
In first, autoimmune patients respond to allogeneic CAR-T cells
Jul 17, 2024 3:26pm
Sanofi tries to quiet naysayers with data on Principia MS drug
Oct 14, 2021 10:05am
